CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- 4 Planned sale Bd. Co-Chair, President & CEO sold 22,830 shares at an average $979.23 ($22,355,714)
- 4 Planned sale Bd. Co-Chair, President & CSO sold 50,000 shares at an average $972.73 ($48,636,545)
- 4 Planned sale Bd. Co-Chair, President & CSO sold 50,000 shares at an average $975.87 ($48,793,727)
- 4 Planned sale Bd. Co-Chair, President & CEO sold 35,941 shares at an average $979.58 ($35,207,110)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- UPLOAD Other SEC-generated Letter
- 4 Option exercise Director acquired 2,000 shares (option exercise)
- 4 Planned sale EVP Commercial sold 250 shares at $889.41 ($222,353)
- 4 Planned sale Director sold 100 shares at an average $899.61 ($89,961)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Gift Bd. Co-Chair, President & CSO gave 36,296 shares (gift)
- 4 Planned sale Bd. Co-Chair, President & CSO sold 16,848 shares at $900.00 ($15,163,200)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale Director sold 100 shares at an average $962.53 ($96,253)
Page 12 of 125 · 2,493 filings